234 related articles for article (PubMed ID: 18827733)
1. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
Dyer D; Callanan D; Bochow T; Abraham P; Lambert HM; Lee SY; Schneiderman T; Potts SL; Walker TM
Retina; 2009 Jan; 29(1):38-45. PubMed ID: 18827733
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
3. [Preservative-free triamcinolone versus purified triamcinolone preparations].
Spitzer MS; Ziemssen F; Yörük E; Bartz-Schmidt KU; Schultheiss M; Szurman P
Klin Monbl Augenheilkd; 2011 Jul; 228(7):626-30. PubMed ID: 21117016
[TBL] [Abstract][Full Text] [Related]
4. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy.
Yamakiri K; Sakamoto T; Noda Y; Nakahara M; Ogino N; Kubota T; Yokoyama M; Furukawa M; Sonoda Y; Yamada T; Doi N; Enaida H; Hata Y; Ishibashi T
Ophthalmology; 2007 Feb; 114(2):289-96. PubMed ID: 17270679
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
6. Triamcinolone-assisted vitrectomy in pediatric cataract surgery.
Shah SK; Vasavada V; Praveen MR; Vasavada AR; Trivedi RH; Dixit NV
J Cataract Refract Surg; 2009 Feb; 35(2):230-2. PubMed ID: 19185235
[TBL] [Abstract][Full Text] [Related]
7. [Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
Mańkowska A; Rejdak R; Oleszczuk A; Kiczyńska M; Łekawa A; Choragiewicz T; Zagórski Z
Klin Oczna; 2008; 110(4-6):151-4. PubMed ID: 18655452
[TBL] [Abstract][Full Text] [Related]
8. Outcome of paediatric cataract surgery with primary posterior capsulotomy and anterior vitrectomy using intra-operative preservative-free triamcinolone acetonide.
Gupta R; Ram J; Sukhija J; Singh R
Acta Ophthalmol; 2014 Aug; 92(5):e358-61. PubMed ID: 24730623
[TBL] [Abstract][Full Text] [Related]
9. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane.
Matsumoto H; Yamanaka I; Hisatomi T; Enaida H; Ueno A; Hata Y; Sakamoto T; Ogino N; Ishibashi T
Retina; 2007 Feb; 27(2):174-9. PubMed ID: 17290199
[TBL] [Abstract][Full Text] [Related]
10. Experimental use of estriol for visualizing the vitreous body in the anterior chamber after posterior capsule rupture in animal models.
Huang R; Kaji Y; Fukuda S; Oshika T
J Cataract Refract Surg; 2009 Jul; 35(7):1260-5. PubMed ID: 19545818
[TBL] [Abstract][Full Text] [Related]
11. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
12. Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation.
Kaynak S; Celik L; Kocak N; Oner FH; Kaynak T; Cingil G
J Cataract Refract Surg; 2006 Jan; 32(1):56-9. PubMed ID: 16516779
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy.
Paccola L; Jorge R; Barbosa JC; Costa RA; Scott IU
Acta Ophthalmol Scand; 2007 Sep; 85(6):603-8. PubMed ID: 17459031
[TBL] [Abstract][Full Text] [Related]
14. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
15. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T
Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254
[TBL] [Abstract][Full Text] [Related]
16. Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibility.
Spitzer MS; Mlynczak T; Schultheiss M; Rinker K; Yoeruek E; Petermeier K; Januschowski K; Szurman P
Retina; 2011 Nov; 31(10):2050-7. PubMed ID: 21747324
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
[TBL] [Abstract][Full Text] [Related]
18. Introduction of a new method for the preparation of triamcinolone acetonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy.
Kumagai K
Retina; 2003 Dec; 23(6):881-2. PubMed ID: 14707849
[No Abstract] [Full Text] [Related]
19. Visualizing vitreous using Kenalog suspension.
Burk SE; Da Mata AP; Snyder ME; Schneider S; Osher RH; Cionni RJ
J Cataract Refract Surg; 2003 Apr; 29(4):645-51. PubMed ID: 12686230
[TBL] [Abstract][Full Text] [Related]
20. Visualization of residual perfluorocarbon liquid using intravitreal triamcinolone acetonide.
Hirata F; Tamura H; Ogura Y
Ophthalmic Surg Lasers Imaging; 2005; 36(2):169-72. PubMed ID: 15792323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
